The FDA announced on Aug. 13, 2025, that Beta Bionics, Inc. is recalling the iLet Ace Pump Kit (REF: BB1001) due to a software flaw allowing unauthorized access. This vulnerability could lead to severe hypoglycemia if users bypass security screens. Owners should contact the company for a remedy.
How to tell if you have it
- Brand: Beta Bionics
- Product: iLet Ace Pump Kit REF: BB1001 iLet Dosing Decision Software
- Affected Units: ILet Ace Pumps containing software version BOM000036 Rev C (version 1.4.2) or older
- Quantity: 15 units
The hazard
According to the FDA, versions 1.3.7, 1.4.2, and 1.4.3 of the iLet graphical user interface display active icons on the Lock Screen and Limited Access Passcode Screen status bar. Pressing these icons allows users to bypass security screens, enabling unauthorized access while the device is in Limited Access Mode. The agency states this could result in severe hypoglycemia due to unauthorized meal announcements or stopped insulin delivery.
Context
GovInfoNow's records show Beta Bionics, Inc. has two other recalls on record since Sept. 23, 2025. On March 12, 2026, the company recalled iLet Bionic Pancreas Software 1.4.2/1.4.3 due to delayed glucose readings risk. Other recent recalls of similar products include Medtronic MiniMed 780G Insulin Pump Recall: Software Error Causes Insulin Stoppage (May 27, 2026), Medtronic MiniMed 780G Insulin Pump Recall: Risk of Incorrect Insulin Delivery (July 13, 2026), and Medtronic MiniMed 640G Insulin Pump Recall: Risk of Incorrect Insulin Delivery (July 13, 2026).